Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice
about
Neuregulin 1 and susceptibility to schizophrenia.Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo Activity.Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotionGABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaineCinnarizine has an atypical antipsychotic profile in animal models of psychosis.D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.Genetic variance contributes to dopamine receptor antagonist-induced inhibition of sucrose intake in inbred and outbred mouse strainsAge-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in ratsPharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(E)-4-(2-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)vinyl)-6-(pyrrolidin-1-yl)pyrimidin-4-yl)morpholine] in rats: potBlockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.Activity-dependent depression of medial prefrontal cortex inputs to accumbens neurons by the basolateral amygdala.Dopamine receptor antagonists prevent the d-amphetamine-induced increase in calcitonin gene-related peptide levels in ventral striatum.Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors.Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.Blocking alpha2A adrenoceptors, but not dopamine receptors, augments bupropion-induced hypophagia in rats.Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.N-oleoyl-dopamine increases locomotor activity in the rat.Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia.
P2860
Q24616921-BCD6F632-5BF7-44B4-AD25-8631B57BA4FAQ30371601-8A2DCDBF-8ACF-4082-BCB1-019B4A745E32Q30412810-B4141335-A540-428B-91F7-8C791E03085BQ33502757-9EE1642E-2273-48A6-A06D-81EAA3FE4EDAQ34162681-4732EAE5-6CD8-4CDE-8EDC-3F5B5A8CD762Q34197072-CB00D230-0565-4D7D-B4DC-AB5E9B76BF99Q34528033-4D2EA9AB-0329-4725-B80A-E465E5B0E1D8Q34558887-BE1C7AD9-5FCB-4B60-AA06-EA5B909AF9EEQ35809256-869F7FA9-4712-4F52-A173-54412DEC9D75Q36456003-DCF1B555-7905-4831-A73F-83ACA7804055Q36517227-CBF94FD0-E1DD-4CF6-B45D-8D1F37E908EAQ36864001-61A7DD5C-8432-4A59-B0AB-D05CBF321140Q37107329-DB928355-9260-48CC-A4AB-801C80F6B65FQ37251016-34752BF6-E230-4749-A602-6C3ABA724BC7Q37417150-70CFD65D-0EC8-42B5-A49B-0A77A65AF032Q37591807-A860FEA2-42D3-494C-8755-D93CBF80ADB6Q38430705-921B3C51-F0CC-47EF-9E4D-31E6265F6FF5Q41012154-E6D7BC42-3B6A-4862-8668-0FAC676258DAQ43634200-0CE0D1F3-D6C4-4FC1-913E-9A8FEBCBF054Q43815277-F62951A0-DB19-4C22-AA8B-F9DBF34A043DQ44059836-21273F0B-F366-47FB-A0EC-F3EA52D5DC4BQ44317537-014A1601-F205-40D4-8A98-74E709357773Q44518965-CDC6133D-786A-46F5-B797-2DDB3C552EC1Q46563220-11317E94-C4EE-4086-9073-1AE09DC5B413Q48339448-25623F89-D978-4BA2-B13A-E0204F57CCE5Q50531661-2A486B4D-7408-4ECE-A482-D268B850B421
P2860
Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@ast
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@en
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@nl
type
label
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@ast
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@en
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@nl
prefLabel
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@ast
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@en
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@nl
P3181
P356
P1433
P1476
Comparison of dopamine recepto ...... amine D1 agonist C-APB in mice
@en
P2093
P2888
P304
P3181
P356
10.1007/S002130051055
P407
P577
1999-08-01T00:00:00Z
P6179
1024851640